<SEC-DOCUMENT>0001144204-13-031123.txt : 20130522
<SEC-HEADER>0001144204-13-031123.hdr.sgml : 20130522
<ACCEPTANCE-DATETIME>20130522165239
ACCESSION NUMBER:		0001144204-13-031123
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20130522
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20130522
DATE AS OF CHANGE:		20130522

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apollo Medical Holdings, Inc.
		CENTRAL INDEX KEY:			0001083446
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				870042699
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0131

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-25809
		FILM NUMBER:		13865391

	BUSINESS ADDRESS:	
		STREET 1:		450 NORTH BRAND BLVD.,
		STREET 2:		SUITE 600
		CITY:			GLENDALE
		STATE:			CA
		ZIP:			91203
		BUSINESS PHONE:		818-507-4617

	MAIL ADDRESS:	
		STREET 1:		700 N. BRAND BLVD.,
		STREET 2:		SUITE 450
		CITY:			GLENDALE
		STATE:			CA
		ZIP:			91203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SICLONE INDUSTRIES INC
		DATE OF NAME CHANGE:	19990413
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v346017_8k.htm
<DESCRIPTION>8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B> &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(d) OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
May 22, 2013</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APOLLO MEDICAL HOLDINGS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; padding-right: 0.8pt; text-align: center"><FONT STYLE="font-size: 10pt">Delaware</FONT></TD>
    <TD STYLE="width: 2%; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="width: 31%; padding-right: 0.8pt; text-align: center"><FONT STYLE="font-size: 10pt">000-25809</FONT></TD>
    <TD STYLE="width: 2%; padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="width: 31%; padding-right: 0.8pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>20-8046599</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font-size: 10pt">(State or Other Jurisdiction</FONT></TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font-size: 10pt">(Commission File</FONT></TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font-size: 10pt">(I.R.S. Employer</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font-size: 10pt">of Incorporation)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font-size: 10pt">Number)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt; text-align: center"><FONT STYLE="font-size: 10pt">Identification Number)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">700 N. Brand Blvd., Suite 450, Glendale,
CA 91203</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)
(zip code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(818) 396-8050</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant's telephone number, including
area code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">N/A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed
since last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Wingdings">&uml;</FONT> Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 5.02 Departure of Directors or
Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 22, 2013, the Board of Directors
(&ldquo;Board&rdquo;) of Apollo Medical Holdings, Inc. (the &ldquo;Company&rdquo;) elected David G. Schmidt, 65, as an independent
member of the Board. Mr. Schmidt entered into the Company&rsquo;s form of Director Agreement, which entitles him to receive a fee
of $1,000 per Board meeting attended, as well as a grant of 400,000 restricted shares of the Company&rsquo;s common stock for his
Board service. These restricted shares will vest evenly on a monthly basis over a 3-year period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 22, 2013, the Company issued a press
release announcing the election of Mr. Schmidt to the Board, which press release is attached hereto as Exhibit 99.1 and incorporated
herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Item 9.01 Financial Statements and Exhibits.
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 96%; padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-size: 10pt">(d) Exhibits. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-right: 0; padding-left: 0; text-align: justify"><FONT STYLE="font-size: 10pt">The following exhibit is furnished as part of this report.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt 0; width: 4%">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt 0; font-size: 10pt; text-align: justify; width: 11%"><FONT STYLE="font-size: 10pt"><B><U>Exhibit No.</U></B></FONT></TD>
    <TD STYLE="padding: 1.5pt 0; width: 2%">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt 0; font-size: 10pt; text-align: justify; width: 83%"><FONT STYLE="font-size: 10pt"><B><U>Description</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.5pt 0">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt 0">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt 0">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt 0">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.5pt 0">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt 0; font-size: 10pt"><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="padding: 1.5pt 0">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt 0; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Press Release dated May 22, 2013 and titled &ldquo;Apollo Medical Holdings Announces the Appointment of David G. Schmidt to Its Board of Directors&rdquo;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>SIGNATURE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 54%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 40%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="padding: 1.5pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B>APOLLO MEDICAL HOLDINGS, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Date: May 22, 2013</FONT></TD>
    <TD STYLE="padding: 1.5pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; padding: 1.5pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">/s/ Warren Hosseinion</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Warren Hosseinion</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>EXHIBIT INDEX </B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 88%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>Exhibit No.</U></B></FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>Description</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding: 1.5pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="padding: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding: 1.5pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Press Release dated May 22, 2013 and titled &ldquo;Apollo Medical Holdings Announces the Appointment of David G. Schmidt to Its Board of Directors&rdquo;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;<B><I>&nbsp;</I></B></P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>&nbsp;</I></B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v346017_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 118px; width: 341px">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 10pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="text-transform: uppercase"><B>Apollo
Medical Holdings Announces the Appointment of </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>David
G. Schmidt to its Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white"><B><I>GLENDALE,
CA &minus; (PR Newswire) &ndash; May 22, 2013 &minus;</I></B> <B>Apollo Medical Holdings, Inc.</B> (&quot;ApolloMed&quot;) (OTCQB:AMEH),</FONT>
an integrated physician-driven healthcare delivery company that puts &lsquo;Patients First,&rsquo; today announced the appointment
of David G. Schmidt as an independent member of its Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 88.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Schmidt is currently a Principal of Schmidt
&amp; Associates, a consultancy practice that focuses on strategic planning and implementation in the healthcare industry. From
2002 to 2010, he served as the CEO and Member of the Board of SCAN Health Plan, the tenth largest Medicare Advantage plan in the
country. With revenues exceeding $1.8 billion, the Company served more than 130,000 Medicare beneficiaries, including a large number
of individuals receiving both Medicare and Medicaid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Prior to joining SCAN, Schmidt served as
CEO of Medicheck, a firm that provided Internet-based financial service management to healthcare organizations. He led the Company
from development stage through its sale to a healthcare IT company, Passport Health Communications. He then served on Passport&rsquo;s
Board for four years. Prior to Medicheck, Schmidt was the Senior Vice President of Sales and Customer Services for Care America/Blue
Shield Health Plan and Regional Vice President for FHP Healthcare. He received a BA in Economics from UCLA and an MBA from The
Anderson School of Management at UCLA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;We are honored to have David join
our Board of Directors,&rdquo; stated Warren Hosseinion, MD, Chief Executive Officer of ApolloMed. &ldquo;His wealth of industry
experience in working with the specialized needs of high growth healthcare companies should prove invaluable to us as we persist
in executing strategies to nationally distinguish ApolloMed as a noted leader in integrated healthcare delivery.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;I am very pleased to be joining
the ApolloMed team, as I believe their physician-driven, patient-centric approach to healthcare delivery will prove to be part
of the solution to our country&rsquo;s healthcare crisis,&rdquo; added Schmidt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Apollo Medical Holdings, Inc.
(ApolloMed)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: black">Headquartered
in Glendale, California and dedicated to putting the &lsquo;Patient First,&rsquo; ApolloMed is a physician-driven integrated healthcare
delivery company, fueled by its commitment to provide exceptional multi-disciplinary care in the communities it serves in Southern
and Central California.&nbsp; ApolloMed is addressing the healthcare needs of the nation&rsquo;s largest population center by leveraging
its integrated healthcare delivery platform through its complementary physician groups:&nbsp; ApolloMed Hospitalists and ApolloMed
ACO (Accountable Care Organization).&nbsp; This platform combines hospitalist medicine, critical care medicine, patient care coordination,
case management and transition management&nbsp;that enable healthcare organizations to engage in performance payments for utilization
efficiency, quality of care objectives and shared accountability arrangements.&nbsp;&nbsp;ApolloMed strives to improve medical
outcomes with high quality, cost efficient care.&nbsp;&nbsp;For more information, please visit&nbsp;</FONT><B>www.apollomed.net</B><FONT STYLE="color: black">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>This press release may contain forward-looking
statements, including information about management's view of future expectations, plans and prospects for Apollo Medical Holdings,
Inc. (&ldquo;the Company&rdquo;).&nbsp; In particular, when used in the preceding discussion, the words &ldquo;predicts,&rdquo;
&quot;believes,&quot; &quot;expects,&quot; &quot;intends,&quot; &ldquo;seeks,&rdquo; &ldquo;estimates,&rdquo; &quot;plans,&quot;
&quot;anticipates,&quot; and similar conditional expressions or future or conditional verbs such as &ldquo;will,&rdquo; &ldquo;may,&rdquo;
&ldquo;might,&rdquo; &ldquo;should,&rdquo; &ldquo;would&rdquo; and &ldquo;could&rdquo; are intended to identify forward-looking
statements.&nbsp; In addition, our representatives may from time to time make oral forward-looking statements. Any such statements,
other than those of historical fact, about an action, event or development, are forward-looking statements.&nbsp;Such statements
are based on the current expectations and certain assumptions of the Company&rsquo;s management. Such statements are, therefore,
subject to a variety of known and unknown risks, uncertainties and other factors, many of which are beyond the control of the Company,
which could cause the actual results, performance or achievements of the Company, its subsidiaries and concepts to be materially
different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends.&nbsp;
Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company&rsquo;s
actual results, performance or achievements may vary materially from those described in the relevant forward-looking statement
as being expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also
could have material adverse effects on the Company&rsquo;s future results.&nbsp; The forward-looking statements included herein
are made only as of the date hereof.&nbsp; The Company cannot guarantee future results, levels of activity, performance or achievements.&nbsp;
Accordingly, you should not place undue reliance on these forward-looking statements.&nbsp; Finally, the Company undertakes no
obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after
the date the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information
prepared by third parties that are not paid for by the Company. You should not place undue reliance on any forward-looking statement
and should consider the uncertainties and risks discussed under Item 1A. &ldquo;Risk Factors&rdquo; of the Company&rsquo;s Annual
Report on Form 10-K for the year ended January 31, 2013 and in any of the Company&rsquo;s other subsequent Securities and Exchange
Commission filings.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR ADDITIONAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>HANOVER|ELITE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Dodi Handy or Kathy Addison</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">407-585-1080 or via email at <B>AMEH@hanoverelite.com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="image_002.jpg" ALT="Description: Capture" STYLE="height: 61px; width: 56px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>



<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!PD'!@H)"`D+"PH,#QD0#PX.
M#QX6%Q(9)"`F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$!`)C!&2T4^2CD_0#W_
MVP!#`0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P``1"`!V`54#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB
M@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`
M"DS@<U5OK^.S3GF0]%K+^VR3MEVZ]ATJXP;5R7)+0W=RGH13JRH9NG-:$4NX
M8-)QL-.Y+1114C"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"F22"*)G;[
MJC)I]9NOR&+1+IEZA?ZTXJ[2%)V5SFIKYKNZ>9C]X\>PJ>*6L>*3I6UHUDU_
M,<Y$2?>/K[5Z$THHY(MR9=@8L,Y`4?Q,<`?C4XU6R@($EY$#Z#FM"?3[:YM?
MLTL0,7]WI7(ZSX5-BIGM,O!W7NO_`-:N>')4=I.QK/G@KI7.MMM0M;C`BN(G
M/H&Y_*K=>5K"48,A*L.A'!KH]$\1S6SK!?,9(CP'/5:JIAFE>+N3#$7TDCL:
M*16#J&4Y!Y!%+7(=(45DZYXGTSP]&&U"X"LWW8UY8_A7-?\`"V=(WX^SW&,_
M>XH`[NBLG0_$VF^(8F;3YP[+]Y#PP_"FZ[XHT[PX8AJ,C)YOW=JYH`V**YA?
MB#H3:9)?"Y(C1MF"OS,?0"J-G\4]%N;D12B:W5C@.XR/TH`[6BF1R)-&LD;!
MD89#`Y!%9&N^+-+\/`"^N!YI&1&O+'_"@#:HKA4^+.CM(`\%PB_WB`:ZS2=9
MLM;M!<Z?.LL?0XZCZCM0!S/C#QY+X8U..UCLTF#INW,Q%:/@_P`4/XGTZ>YD
MMUA,3[<*<YXK@OBQ_P`C'!_UQKH/A-_R`+W_`*Z_TH`HWOQ:N+6[N(1IL3")
MV7.\\X->CV5P;JQM[@C:98U<CTR,U\ZZO_R%+[_KL_\`.OH32#C1+'/3[/'_
M`.@B@"[17*ZO\1-%TFX:#S6N)5.&6(9`_&JEG\4]$N9@DPFMP3@,XR/TH`[6
MBHX9H[B%9H75XW&593D$5COXOTN.5HVD?<IVGY3UJHPE+X43*<8[LW**P[[Q
M9I]DX3<TK]2$[5+I?B2QU60QQ,4EQG8_&15>RFES6T%[2%[7->BN?N_&6G6T
MQC3?,5."4Z5H:7K5IJZ,;9_F7[R'J*'2FES-:`JD&[)FA14-S<Q6D+2SR*D:
M]2:P9?&^GHY")+(/4#%*-.4_A02J1C\3.DHK+TSQ#8ZJ_EP2;9>NQN#6D[K&
MA=V"JHR2>U3*+B[-%*2DKH=6)XBUY]$%N4A63S21R<8Q4$_C73HIBB"20`XW
M*.*QO%VI6VJ6MC-:R;EW-D=QP*Z*5"7.N=:&%6LN5\KU.@\.Z^^M_:-\*Q^4
M1T.<YK;KCO`'2^^J_P`C78U%>*C4:1=&3E!-A1116)J%%%%`"$X%9VJ1?:]/
MN8!U9#C\.:O3-M2L^28JX8=0:N"UNB9;6.`CD(X.<CM7HNCVHM-,A4#YF7<Q
M]2:X_6],^SW8OH!FVD<%P/X#WS[5W5N0;:(KT*#'Y5TXF?-%6.>A&TFF/H*A
M@01D'@BEHKC.HXK5],%G?,$'[M_F7VJCY%=9KT(DCB;'()K%\BN^G4;BKG+.
M"3T-?PW=-):-`YR8NA/I6S6!HB%+X^A0UO\`:N2JO>T-Z?PGA7BFVU75?%-[
M,]G<NOG&.-O+)`4'`KJ-3^'&G67A)[M995NXHA(78\$\9&*L>*?B=]@O9;/1
MX(Y'B.UYI/NY[X%<M>7'BSQ+82W%R9S8JN\Y&Q,>WK6993\#7<EIXOL7C)&]
MMC`=P:ZWXP?>T[\:XSPC_P`C7I__`%T%=G\8/O:=^-`'+^#/"W_"5:C+#+,\
M5M`N]RO4YXXJ+QCX:'AC6!:I(TL,B;T9NN/0UU_P@5=FH-_%D#\*K?%Y1]NL
M#CG81F@#;^'.MLW@R8W#;OL)8#)_A`R*\NN)KG7]=9Y&+W%U-@'ZFNL\%R./
M!?B,#A1"2#[X-<MX9_Y&33/^NZT`=MXH^'-GI/AA[VSDD-Q;J&D+'AAWK#^&
M^JR:?XJ@@#'RKO\`=LO;/4&O5_%:A_"NI*PR#`V17BGA'_D;-,_Z["@#HOBQ
M_P`C'!_UQKH/A-_R`+W_`*Z_TKG_`(L?\C'!_P!<:Z#X3?\`(`O?^NO]*`/+
MM7_Y"E]_UV?^=>N^*M7DTGX>6[0-MFFMXXU/IE1G]*\BU?\`Y"E]_P!=G_G7
MH?Q'8CP7H0!X.S/O^[%`')>#?#R^)-=6VF9E@12\K+U_R:T/'_A*W\-7%M)9
MLQM[C(VMSAA5_P"$?_(>O?\`KB/YUM?%Y0='L21R)CC\J`&_";59+C3KO3Y6
M+"W(=,]@>U8]Y_Q^S?[Y_G3_`(1EAJU^`,J8AD^E,N_^/Z;_`*Z'^==V"WD<
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M^,+,4C098CK3_$&B_P!BW:(CEXI!E2>M:_@$`W%Z>X5?ZT_Q\!_H)[Y8?RH]
MK+V_)T#V<?8\_47P!TOOJO\`(UV-<=X`Z7WU7^1KL:X\3_%9U8?^&@HHHK`W
M"BBB@"&Z!,)([<UCS/6Z1D$'H:PM1MVMGSC,9Z&M:36Q$^Y3:=H\XP5/!4\@
MU?M_$,"(J31E`HP-O(K&E>J<CUT^S4MS#G<=CJV\1Z>HYD;_`+YK+U#Q@`A6
MRB.3T=_\*YR1JOZ'HSZG<B652+9#EB?XO84_84X+FD2ZLY/E1N6B3/I4!N&9
MI9"9&W=1FG>1[5IM%D\#`'`'H*!;Y/`KGYSH4>A%IMOLD9\=L5<N<_99=O78
M<?E3XT$:!13JQD[NY:5D?-I.W4\W`Z3@R#VW<U[%XH\2:/!X1F2WN86\Z';#
M%&1DY]JRO$7PN.H:G+=Z;<K$)FW/&XX!/4@U%I/PF$<K/JEV)0%(2-!QG'!)
MI#.'\(<>*M/_`.N@KM/C!][3OQI^F_"R\TW4K>[CU2,M"X;'E]1GI4?Q@^]I
MWXT`9/PT\06FC:I<Q7\JQ17"`+(W`!'J:A^(^NVVM:[$+&42P01[=XZ%L]J;
MX1\(1>*M,O!YIAN(6&Q\9!]B*V+7X0W)G475^BP@_-L7DT`7/AWI3W/@K4P1
MC[4710>_%>=6$YTO68)W7FVGR5/L:^A-.T^#2["&SM4V0Q+M45Q_BCX:0:Q>
MO>V$XM9GYD0KE6/K[4`3^-/$^G/X-N!;W<4DEW'L14;)Y[UYWX!L7O?&%EL&
M5@;S7^@K=7X1Z@64-?1!>YQG%=WX6\(V?A>V80DRW$G^LE8<GV'H*`//OBQ_
MR,<'_7&N@^$W_(`O?^NO]*M^,?`<WB?4X[J.\6$(FW:5S6EX.\+R>&-.GMI+
MA9S*^[<%QCB@#Q'5_P#D*7W_`%V?^=>H>.[%KKX>6$R+G[/'$Y^A4"J%[\)+
MFZN[B8:FBB5V8#R^F37HD>GQG2(["Y42QB%8G!'#8&*`/'OAOK%OI/B0BZ=8
MXKA-F]N@/:M?XJZW:W[V5E:3)*8B9'*'(&1C%3ZE\(V-RSZ;?!86.1'(O*_C
M45G\(KEK@&]OU$0Z[!DGVH`G^$-BZIJ%\P_=OB-3[CK5"[_X_IO^NA_G7I^E
MZ5;:/I\=G9)LB08'J3ZFN9F\#32W#R"\4;FW8VUUX6I&#?,SFQ-.4[<J.@;_
M`)%L_P#7#^E>;V7_`!_P?]=!_.O4#9DZ7]EW<^7LW5S$'@::&XCD-XI",&QM
MJL/5A%2NR:].4G&R-GQ9_P`B[<_05Q?A?_D8[3ZG^5=_K&GMJ>F2VJN$+_Q$
M=*P])\'RZ;J<-TUTKB,GY0N,\4J-2,:4HMZCJTY2J*26AB^,K=HM?>1A\LJ`
MJ?H,5O>$]6M4T189IDC>#((8XXZYK5UC1H-9MA'-E77[CCJM<NW@2Z#$)=(1
MZXQFFJE.I34)NUB7"=.HY15[E2\\4ZE+?R"UG(C9\1J!6QXR@DDT.TFDR6C(
MW'W(J71_!T5C<K<74OG.G*J!@`_UKH+NUBO;9X)UW1N,$4IU:<9QY%L5"E.4
M9<[W."\):G#IVHN+A@D<JXW'H#3_`!?JD&HWD*6SATB!RPZ$FK4W@.82GR;E
M3'VW#D5.W@0?9$5+D";.68CC'H!6SJ4>?VE]3%0J\G)83P#TOOJG\C78UB>'
M=`?1/M&^82^:01@8QBMNN.O)2J-HZZ,7&"3"BBBL34****`"FNBR(5=0RGJ#
M3J*`,:[\/1RDF"0Q^QY%9S^%KIF_UJ8]:ZJDK6-::,W2BSG[3PE;QL'NI&F(
M_A'`K>CB2*,)&H5!P`!3Z*F4Y3^)E1@H["8%&*6BH*"BBB@!*6BB@!*X;XC^
M&]1U]K/^SHA)Y>=V3C%=U24`<3\.?#NH:!%>+J$0C,C`K@YKMZ**`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"DI:*`$HI:*`"BBB@!*6BB@!**6B@`HHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`H
MHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BB
MB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****
M`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`
"_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!PD'!@H)"`D+"PH,#QD0#PX.
M#QX6%Q(9)"`F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$!`)C!&2T4^2CD_0#W_
MVP!#`0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P``1"``]`#@#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:DHK/U2_
M^S*L:$>8_P"@II<SLA-V+KS1H<%AGTI5D5NAK`AG).2<D]ZT;>4D\#/TJW3L
M2I7-&BF(Q(Y!IU9EBT444`(:Y+6)RVL3`_P8`KJI&VK7)>(H3%>K<@?)*,$^
MC"M\.O>,JWPES2K9KR0YXC7J?Z5HZAI+7,(%M<20%1PJGY3]:DT6$1:7#@<L
M-QJ_4SF^;0<8)QU.$=;^QG*&:6-U/][K6WI.ON[K!>XR>%D']:N:Y9K-`)@/
MGC/7U%87V?VK=.-6.J,K.F]#L0:*J:;,TMBA?EA\I_"BN-JSL="U'7;%<>XK
M+NO+FB>*==\;CD=Q[CWK8N(?.B('WATK`N2R.5<88=C6U/4B9JZ=<01VD4/G
MABBXRW!JS)>6\2EGFC`'^U7(S/541R7,HCA4NYZ`5I[!/5LCVMM$=0-4CU%I
MXK=2T:+RY[GVJ#[/ZBK6FZ6+&S$1Y=CN<^]6Q;@GVK/F47:.Q:3:NQMA'Y=L
M!ZDFBK0```'045B]7<T6@5%-;Q7`Q*BL/>IJ*`,UM!LF;)1L>F[BK5O9P6JX
:@B5/<#FK%%4Y-Z7%RH3'%+114C"BBB@#_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
